EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹140 Cr | ₹160 Cr | ₹138 Cr | ₹113 Cr | ₹77 Cr |
What is the latest Total Current Liabilities ratio of EVEREST ORGANICS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹140 Cr |
| Mar2024 | ₹160 Cr |
| Mar2023 | ₹138 Cr |
| Mar2022 | ₹113 Cr |
| Mar2021 | ₹77 Cr |
How is Total Current Liabilities of EVEREST ORGANICS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹140 Cr | -12.55 | |
| Mar2024 | ₹160 Cr | 16.30 | |
| Mar2023 | ₹138 Cr | 22.23 | |
| Mar2022 | ₹113 Cr | 45.50 | |
| Mar2021 | ₹77 Cr | - | |
Compare Total Current Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹217.1 Cr | -1.5% | -38.3% | -10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -1.5% |
-38.3% |
-10% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses